Learn More
Medchemexpress LLC 3-[4-[4-(4-bromobenzoyl)-3-(4-chlorophenyl)piperazine-1-carbonyl]-5-methylpyrazol-1-yl]benzonitrile | 2095486-67-0 | 100.0% | 588.88 g/mol | C29H23BrClN5O2 | 25 MG

Supplier: Medchemexpress LLC HY10151325MG
eIF4A3-IN-1 is a selective small-molecule inhibitor of the eukaryotic initiation factor 4A3 (eIF4A3) intended for research use. It inhibits nonsense-mediated RNA decay (NMD), binds the non-ATP site of eIF4A3, and has reported anti-tumor and analgesic activities. Chemical identity: C29H23BrClN5O2, MW 588.88 g/mol, CAS 2095486-67-0; purity 99.96%.
- selective eIF4A3 inhibition (IC50 0.26 μM; Kd 0.043 μM).
- high reported purity of 99.96%.
- soluble in DMSO at 200 mg/mL (requires sonication) for in vitro use.
- formulation compatible with in vivo vehicle of 10% DMSO/90% corn oil at ≥5 mg/mL.
- powder and solution storage recommendations for compound stability.
- available in multiple solid package sizes, including a 25 mg option.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.